Literature DB >> 30078050

Hepatocyte-specific contrast media: not so simple.

Andrew T Trout1, Alexander J Towbin2, Ethan A Smith2, Anita Gupta3, Jonathan R Dillman2.   

Abstract

Hepatocyte-specific contrast media are gadolinium chelates that are taken up by hepatocytes and partially cleared via the biliary tree. The absence of lesional uptake of the contrast media in the hepatobiliary phase is a marker of either the absence of hepatocytes or of poorly functioning, neoplastic hepatocytes. Uptake of the contrast media in the hepatobiliary phase, whether equal to or greater than background liver, reflects the presence of hepatocytes but does not equate to absence of neoplasia. Accurate diagnosis of liver lesions utilizing hepatocyte-specific contrast media requires an understanding of the mechanisms of uptake and clearance of the contrast media to avoid misdiagnosis. In this review we discuss the mechanisms of hepatocellular transport of hepatocyte-specific contrast media and utilize an understanding of those mechanisms to discuss the imaging appearance of a subset of hepatocellular lesions that can be seen in the pediatric and young adult liver. We pay particular attention to lesions that appear iso- to hyperintense in the hepatobiliary phase but have the potential for adverse clinical outcomes. We also discuss strategies for identifying these lesions.

Entities:  

Keywords:  Adenoma; Children; Focal nodular hyperplasia; Hepatocellular carcinoma; Hepatocyte-specific contrast media; Liver; Magnetic resonance imaging

Mesh:

Substances:

Year:  2018        PMID: 30078050     DOI: 10.1007/s00247-018-4108-x

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  28 in total

Review 1.  The role of hepatocyte-specific contrast agents in hepatobiliary magnetic resonance imaging.

Authors:  Chistopher Burke; Lee Alexander Grant; Vicky Goh; Nyree Griffin
Journal:  Semin Ultrasound CT MR       Date:  2013-02       Impact factor: 1.875

Review 2.  Hepatobiliary agents and their role in LI-RADS.

Authors:  Thomas A Hope; Kathryn J Fowler; Claude B Sirlin; Eduardo A C Costa; Judy Yee; Benjamin M Yeh; Jay P Heiken
Journal:  Abdom Imaging       Date:  2015-03

Review 3.  Hepatocellular adenoma: Classification, variants and clinical relevance.

Authors:  Paulette Bioulac-Sage; Christine Sempoux; Charles Balabaud
Journal:  Semin Diagn Pathol       Date:  2016-12-20       Impact factor: 3.464

4.  Hepatocyte transporter expression in FNH and FNH-like nodule: correlation with signal intensity on gadoxetic acid enhanced magnetic resonance images.

Authors:  Norihide Yoneda; Osamu Matsui; Azusa Kitao; Ryuuichi Kita; Kazuto Kozaka; Wataru Koda; Satoshi Kobayashi; Toshifumi Gabata; Hiroko Ikeda; Yasunori Sato; Yasuni Nakanuma
Journal:  Jpn J Radiol       Date:  2012-05-24       Impact factor: 2.374

Review 5.  Focal Nodular Hyperplasia and Hepatocellular Adenoma: Accuracy of Gadoxetic Acid-enhanced MR Imaging--A Systematic Review.

Authors:  Matthew D F McInnes; Rebecca M Hibbert; João R Inácio; Nicola Schieda
Journal:  Radiology       Date:  2015-05-26       Impact factor: 11.105

Review 6.  Genetics and imaging of hepatocellular adenomas: 2011 update.

Authors:  Venkata S Katabathina; Christine O Menias; Alampady K P Shanbhogue; Jaishree Jagirdar; Raj Mohan Paspulati; Srinivasa R Prasad
Journal:  Radiographics       Date:  2011-10       Impact factor: 5.333

7.  Hepatocellular carcinoma: signal intensity at gadoxetic acid-enhanced MR Imaging--correlation with molecular transporters and histopathologic features.

Authors:  Azusa Kitao; Yoh Zen; Osamu Matsui; Toshifumi Gabata; Satoshi Kobayashi; Wataru Koda; Kazuto Kozaka; Norihide Yoneda; Tatsuya Yamashita; Shuichi Kaneko; Yasuni Nakanuma
Journal:  Radiology       Date:  2010-07-27       Impact factor: 11.105

8.  Beta-catenin-activated hepatocellular adenoma showing hyperintensity on hepatobiliary-phase gadoxetic-enhanced magnetic resonance imaging and overexpression of OATP8.

Authors:  Norihide Yoneda; Osamu Matsui; Azusa Kitao; Kazuto Kozaka; Toshifumi Gabata; Motoko Sasaki; Yasuni Nakanuma; Kiyoshi Murata; Toru Tani
Journal:  Jpn J Radiol       Date:  2012-08-23       Impact factor: 2.374

9.  Focal nodular hyperplasia-like areas in cirrhosis.

Authors:  A Quaglia; J Tibballs; A Grasso; N Prasad; P Nozza; S E Davies; A K Burroughs; A Watkinson; A P Dhillon
Journal:  Histopathology       Date:  2003-01       Impact factor: 5.087

10.  The impact of hepatocyte phase imaging from infancy to young adulthood in patients with a known or suspected liver lesion.

Authors:  Amy B Kolbe; Daniel J Podberesky; Bin Zhang; Alexander J Towbin
Journal:  Pediatr Radiol       Date:  2014-09-23
View more
  4 in total

Review 1.  Assessing locoregional treatment response to Hepatocellular Carcinoma: comparison of hepatobiliary contrast agents to extracellular contrast agents.

Authors:  Anum Aslam; Amita Kamath; Bradley Spieler; Mark Maschiocchi; Carl F Sabottke; Victoria Chernyak; Sara C Lewis
Journal:  Abdom Radiol (NY)       Date:  2021-04-15

Review 2.  Intravenous gadolinium-based hepatocyte-specific contrast agents (HSCAs) for contrast-enhanced liver magnetic resonance imaging in pediatric patients: what the radiologist should know.

Authors:  Rama S Ayyala; Sudha A Anupindi; Michael S Gee; Andrew T Trout; Michael J Callahan
Journal:  Pediatr Radiol       Date:  2019-07-26

3.  Congenital Portosystemic Shunts in Children: Associations, Complications, and Outcomes.

Authors:  Frank DiPaola; Andrew T Trout; Ashley E Walther; Anita Gupta; Rachel Sheridan; Kathleen M Campbell; Greg Tiao; Jorge A Bezerra; Kevin E Bove; Manish Patel; Jaimie D Nathan
Journal:  Dig Dis Sci       Date:  2019-09-23       Impact factor: 3.199

4.  Robotic resection of liver focal nodal hyperplasia guided by indocyanine green fluorescence imaging: A preliminary analysis of 23 cases.

Authors:  Cheng-Gang Li; Zhi-Peng Zhou; Xiang-Long Tan; Zi-Zheng Wang; Qu Liu; Zhi-Ming Zhao
Journal:  World J Gastrointest Oncol       Date:  2020-12-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.